JPWO2021074403A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2021074403A5
JPWO2021074403A5 JP2022521684A JP2022521684A JPWO2021074403A5 JP WO2021074403 A5 JPWO2021074403 A5 JP WO2021074403A5 JP 2022521684 A JP2022521684 A JP 2022521684A JP 2022521684 A JP2022521684 A JP 2022521684A JP WO2021074403 A5 JPWO2021074403 A5 JP WO2021074403A5
Authority
JP
Japan
Prior art keywords
formulation according
weight
highly lipophilic
cannabinoids
formulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022521684A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022553653A5 (https=
JP2022553653A (ja
JP7778069B2 (ja
Publication date
Priority claimed from EP19203580.6A external-priority patent/EP3808341A1/de
Application filed filed Critical
Publication of JP2022553653A publication Critical patent/JP2022553653A/ja
Publication of JP2022553653A5 publication Critical patent/JP2022553653A5/ja
Publication of JPWO2021074403A5 publication Critical patent/JPWO2021074403A5/ja
Priority to JP2025169943A priority Critical patent/JP2025182116A/ja
Application granted granted Critical
Publication of JP7778069B2 publication Critical patent/JP7778069B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022521684A 2019-10-16 2020-10-16 高親油性生理活性物質の放出制御製剤 Active JP7778069B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025169943A JP2025182116A (ja) 2019-10-16 2025-10-08 高親油性生理活性物質の放出制御製剤

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP19203580.6A EP3808341A1 (de) 2019-10-16 2019-10-16 Kontrolliert freisetzende formulierungen stark lipophiler physiologisch aktiver substanzen
EP19203580.6 2019-10-16
PCT/EP2020/079248 WO2021074403A1 (de) 2019-10-16 2020-10-16 Kontrolliert freisetzende formulierungen stark lipophiler physiologisch aktiver substanzen

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025169943A Division JP2025182116A (ja) 2019-10-16 2025-10-08 高親油性生理活性物質の放出制御製剤

Publications (4)

Publication Number Publication Date
JP2022553653A JP2022553653A (ja) 2022-12-26
JP2022553653A5 JP2022553653A5 (https=) 2023-10-19
JPWO2021074403A5 true JPWO2021074403A5 (https=) 2023-10-19
JP7778069B2 JP7778069B2 (ja) 2025-12-01

Family

ID=68281185

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022521684A Active JP7778069B2 (ja) 2019-10-16 2020-10-16 高親油性生理活性物質の放出制御製剤
JP2025169943A Pending JP2025182116A (ja) 2019-10-16 2025-10-08 高親油性生理活性物質の放出制御製剤

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025169943A Pending JP2025182116A (ja) 2019-10-16 2025-10-08 高親油性生理活性物質の放出制御製剤

Country Status (10)

Country Link
US (1) US20240139215A1 (https=)
EP (2) EP3808341A1 (https=)
JP (2) JP7778069B2 (https=)
CN (1) CN114945353A (https=)
AU (1) AU2020365443A1 (https=)
BR (1) BR112022006643A2 (https=)
CA (1) CA3157654A1 (https=)
IL (1) IL292018A (https=)
MX (1) MX2022004523A (https=)
WO (1) WO2021074403A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3808336A1 (de) * 2019-10-16 2021-04-21 ADD Advanced Drug Delivery Technologies, Ltd. Kontrolliert freisetzende formulierungen stark lipophiler physiologisch aktiver substanzen
US20240317701A1 (en) 2020-12-17 2024-09-26 Nalu Bio, Inc. Synthesis of cannabidiol and analogs thereof, and related compounds, formulations, and methods of use
GB2618322A (en) * 2022-04-29 2023-11-08 113 Botanicals Ltd Compositions and methods

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1361864T3 (en) * 2001-02-14 2014-03-03 Gw Pharma Ltd FLYLDENDE SPRAY FORMULATIONS FOR buccal administration of cannabinoids
EP1364646A4 (en) * 2001-03-01 2005-08-03 Grelan Pharmaceutical Co FENOFIBRATE CONTAINING COMPOSITION
DE10226494A1 (de) * 2002-06-14 2004-01-08 Lts Lohmann Therapie-Systeme Ag Filmförmige mucoadhäsive Darreichungsformen zur Verabreichung von Cannabis-Wirkstoffen
WO2008024490A2 (en) 2006-08-24 2008-02-28 Theraquest Biosciences, Inc. Oral pharmaceutical formulations of abuse deterrent cannabinoids and method of use
AU2014340709B2 (en) 2013-10-29 2019-07-04 Echo Pharmaceuticals B.V. Compressed tablet containing cannabidiol, method for its manufacture and use of such tablet in oral treatment of psychosis or anxiety disorders
DE102014213548A1 (de) * 2014-07-11 2016-01-14 Hans Brammer Cannabispräparat
HRP20200326T1 (hr) * 2014-08-11 2020-06-12 Perora Gmbh Formulacija koja sadrži čestice
IL246790A0 (en) * 2016-07-14 2016-09-29 Friedman Doron Self-dissolving compounds of cannabinoids
WO2018035030A1 (en) 2016-08-15 2018-02-22 Corr-Jensen Inc. Time release fat-soluble actives
JP2019137614A (ja) * 2018-02-06 2019-08-22 富士フイルム株式会社 経口用医薬組成物及びその製造方法
DE102019100483A1 (de) * 2019-01-10 2020-07-16 Lts Lohmann Therapie-Systeme Ag Oraler Dünnfilm

Similar Documents

Publication Publication Date Title
JP2025182116A5 (https=)
JP2020500876A5 (https=)
ME01944B (me) Farmaceutske kompozicije koje sadrže rozuvastatin kalcijum
RU2009141538A (ru) Твердые лекарственные формы, содержащие тадалафил
JP2025182116A (ja) 高親油性生理活性物質の放出制御製剤
JPWO2021074403A5 (https=)
CN110833531A (zh) 一种维生素e制剂及其制备方法
Pandey et al. Development and evaluation of Herbal Tablet loaded with Pueraria tuberosa water extract with use of different Excipients
US20110142944A1 (en) Andrographis extract formulations
JP2019034925A (ja) 錠剤組成物
CN104870544A (zh) 用于形成复合物的组合物、由此形成的复合物和用于口服的含所述复合物的组合物
TWI230065B (en) Composition comprising ascorbic acid and pectin
JPWO2021074399A5 (https=)
RU2007143556A (ru) Композиции с пролонгированным высвобождением
EA015440B1 (ru) Твердая лекарственная форма, содержащая полиморфную форму 1 клопидогрела гидросульфата
Al-Pokhiti et al. Development and evaluation of sustained release matrix tablets of ketoprofen employing natural polymers (pomegranate peel and acacia powders)
Kushwaha et al. Research article development and evaluation of polyherbal tablet from some hepatoprotective herbs
KR20200123081A (ko) 유용성 물질의 제조 방법, 및 그로부터 수득 가능한 분말
CA2259730A1 (en) Sustained release tablets containing bupropion hydrochloride
RU2789521C2 (ru) Твердая лекарственная форма из семян лимонника китайского и способ ее получения
JP2017506647A (ja) 爪真菌症を治療するための局所用抗真菌薬組成物
CN109419780B (zh) 一种盐酸索他洛尔片剂及其制备方法
CN110772572A (zh) 一种森登-4洗剂及其制备方法
JP2006143685A5 (https=)
JP2026034780A (ja) 高親油性生理活性物質の放出制御製剤